ATP10A
Phospholipid-transporting ATPase VA
Also known as: AT10A_HUMAN, ATP10C, ATPVA, ATPVC, KIAA0566
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60312
- Gene
- ATP10A
- Ensembl
- ENSG00000206190
- Chromosome
- 15
- Canonical length
- 1499 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of aminophospholipid-transporting ATPases. The aminophospholipid translocases transport phosphatidylserine and phosphatidylethanolamine from one side of a bilayer to another. This gene is maternally expressed. It maps within the most common interval of deletion responsible for Angelman syndrome, also known as 'happy puppet syndrome'. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1499 residues, UniProt reviewed canonical sequence.
>O60312|ATP10A
1 MEREPAGTEE PGPPGRRRRR EGRTRTVRSN LLPPPGAEDP AAGAAKGERR RRRGCAQHLA
61 DNRLKTTKYT LLSFLPKNLF EQFHRPANVY FVFIALLNFV PAVNAFQPGL ALAPVLFILA
121 ITAFRDLWED YSRHRSDHKI NHLGCLVFSR EEKKYVNRFW KEIHVGDFVR LRCNEIFPAD
181 ILLLSSSDPD GLCHIETANL DGETNLKRRQ VVRGFSELVS EFNPLTFTSV IECEKPNNDL
241 SRFRGCIIHD NGKKAGLYKE NLLLRGCTLR NTDAVVGIVI YAGHETKALL NNSGPRYKRS
301 KLERQMNCDV LWCVLLLVCM SLFSAVGHGL WIWRYQEKKS LFYVPKSDGS SLSPVTAAVY
361 SFLTMIIVLQ VLIPISLYVS IEIVKACQVY FINQDMQLYD EETDSQLQCR ALNITEDLGQ
421 IQYIFSDKTG TLTENKMVFR RCTVSGVEYS HDANAQRLAR YQEADSEEEE VVPRGGSVSQ
481 RGSIGSHQSV RVVHRTQSTK SHRRTGSRAE AKRASMLSKH TAFSSPMEKD ITPDPKLLEK
541 VSECDKSLAV ARHQEHLLAH LSPELSDVFD FFIALTICNT VVVTSPDQPR TKVRVRFELK
601 SPVKTIEDFL RRFTPSCLTS GCSSIGSLAA NKSSHKLGSS FPSTPSSDGM LLRLEERLGQ
661 PTSAIASNGY SSQADNWASE LAQEQESERE LRYEAESPDE AALVYAARAY NCVLVERLHD
721 QVSVELPHLG RLTFELLHTL GFDSVRKRMS VVIRHPLTDE INVYTKGADS VVMDLLQPCS
781 SVDARGRHQK KIRSKTQNYL NVYAAEGLRT LCIAKRVLSK EEYACWLQSH LEAESSLENS
841 EELLFQSAIR LETNLHLLGA TGIEDRLQDG VPETISKLRQ AGLQIWVLTG DKQETAVNIA
901 YACKLLDHDE EVITLNATSQ EACAALLDQC LCYVQSRGLQ RAPEKTKGKV SMRFSSLCPP
961 STSTASGRRP SLVIDGRSLA YALEKNLEDK FLFLAKQCRS VLCCRSTPLQ KSMVVKLVRS
1021 KLKAMTLAIG DGANDVSMIQ VADVGVGISG QEGMQAVMAS DFAVPKFRYL ERLLILHGHW
1081 CYSRLANMVL YFFYKNTMFV GLLFWFQFFC GFSASTMIDQ WYLIFFNLLF SSLPPLVTGV
1141 LDRDVPANVL LTNPQLYKSG QNMEEYRPRT FWFNMADAAF QSLVCFSIPY LAYYDSNVDL
1201 FTWGTPIVTI ALLTFLLHLG IETKTWTWLN WITCGFSVLL FFTVALIYNA SCATCYPPSN
1261 PYWTMQALLG DPVFYLTCLM TPVAALLPRL FFRSLQGRVF PTQLQLARQL TRKSPRRCSA
1321 PKETFAQGRL PKDSGTEHSS GRTVKTSVPL SQPSWHTQQP VCSLEASGEP STVDMSMPVR
1381 EHTLLEGLSA PAPMSSAPGE AVLRSPGGCP EESKVRAAST GRVTPLSSLF SLPTFSLLNW
1441 ISSWSLVSRL GSVLQFSRTE QLADGQAGRG LPVQPHSGRS GLQGPDHRLL IGASSRRSQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP10A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 19 nTPM
- salivary gland: 9.6 nTPM
- adrenal gland: 8 nTPM
- lung: 7 nTPM
- adipose tissue: 6.1 nTPM
- cerebral cortex: 5.6 nTPM
Single-cell type
- podocytes: 2,439 nCPM
- alveolar cells type 1: 429 nCPM
- vascular smooth muscle cells: 336 nCPM
- innate lymphoid cells: 251 nCPM
- thymocytes: 199 nCPM
- melanocytes: 184 nCPM
Immune cell
- NK-cell: 1.5 nTPM
- plasmacytoid DC: 1.3 nTPM
- naive CD4 T-cell: 0.9 nTPM
- naive CD8 T-cell: 0.9 nTPM
- gdT-cell: 0.7 nTPM
- memory CD8 T-cell: 0.7 nTPM
Brain region
- thalamus: 35 nTPM
- amygdala: 31 nTPM
- midbrain: 22 nTPM
- pons: 22 nTPM
- basal ganglia: 22 nTPM
- medulla oblongata: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP10A.
Disease | ImmuneIEDB
Conditions an epitope on ATP10A was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.76
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- monoatomic ion transmembrane transport
- phospholipid translocation
- positive regulation of membrane tubulation
- regulation of cell shape
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATPase-coupled intramembrane lipid transporter activity
- glycosylceramide flippase activity
- magnesium ion binding
- phosphatidylcholine flippase activity
- phosphatidylcholine floppase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- P-type ATPase, subfamily IV
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- P-type ATPase, C-terminal
- P-type ATPase, N-terminal
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P-type ATPase, cytoplasmic domain N
- Phospholipid-translocating ATPase N-terminal
- Phospholipid-translocating P-type ATPase C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP10A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP10A as an antibody target. Whether an autoantibody or antibody against ATP10A could matter depends on whether native ATP10A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP10A is annotated at the cell surface, where native ATP10A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP10A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...